Related Experiment Video
Updated: Mar 6, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
ERK inhibits Capicua repressor function via multisite phosphorylation
Sayantanee Paul1,2, Khandan Ilkhani1, Nathan Strozewski1
1Department of Biology, University of Massachusetts Boston, Boston, MA 02125, USA.
Abstract:
The receptor tyrosine kinase (RTK)/extracellular signal-regulated kinase (ERK) signaling pathway controls cell proliferation, differentiation and survival. The transcriptional repressor Capicua (Cic) has emerged as a key target for ERK-mediated downregulation in Drosophila and mammals, and pathogenic variants in human CIC result in cancer and neurological diseases. Phosphorylation by ERK (Rolled in flies) is critical for Cic downregulation, but the identities of phosphosites in Drosophila Cic are unknown. Here, we identify sites of phosphorylation in Cic that are directly targeted by ERK and validate their developmental functions in vivo using mutant Cic variants. Cic phosphosites are distributed throughout the length of the protein. Cic mutated in 20 high-confidence sites is resistant to proteasomal degradation and behaves as a 'super-repressor' in vivo that is largely insensitive to ERK-mediated downregulation. No single site is sufficient to turn off Cic activity; instead, we find that ERK must phosphorylate multiple sites in Cic simultaneously to achieve full downregulation. This multisite phosphorylation likely involves phosphodegrons that are recognized by ubiquitin ligases such as Ago (FBXW7 in mammals), contributing to Cic degradation. This study advances our understanding of the molecular mechanisms of signal interpretation downstream of the RTK/ERK signaling network.
Insights
Extracellular signal-regulated kinase (ERK) signaling regulates cell growth and survival. This study identifies key phosphorylation sites on the Capicua (Cic) protein, revealing how ERK controls Cic activity and degradation.
Area of Science:
- Molecular Biology
- Cell Signaling
- Genetics
Background:
- The receptor tyrosine kinase (RTK)/extracellular signal-regulated kinase (ERK) pathway is crucial for cellular functions.
- Capicua (Cic) is a transcriptional repressor targeted by ERK; mutations in human CIC are linked to diseases.
- Understanding Cic phosphorylation by ERK is vital for deciphering its regulatory mechanisms.
Purpose of the Study:
- To identify and characterize specific phosphorylation sites on Drosophila Cic targeted by ERK.
- To validate the in vivo developmental functions of these phosphosites using mutant Cic variants.
- To elucidate the role of multisite phosphorylation in Cic downregulation and degradation.
Main Methods:
- Phosphoproteomic analysis to identify potential ERK target sites on Cic.
- Site-directed mutagenesis to create Cic variants with mutated phosphosites.
- In vivo functional assays in Drosophila to assess the impact of mutations on Cic activity and degradation.
Main Results:
- Identified multiple high-confidence Cic phosphosites directly targeted by ERK.
- Cic mutated at 20 sites showed resistance to proteasomal degradation, acting as a "super-repressor".
- ERK requires simultaneous phosphorylation of multiple Cic sites for full downregulation, suggesting a phosphodegron mechanism.
Conclusions:
- Multisite phosphorylation by ERK is essential for the functional downregulation and degradation of Cic.
- This mechanism involves phosphodegrons recognized by ubiquitin ligases like Ago/FBXW7.
- The findings provide critical insights into signal interpretation downstream of the RTK/ERK pathway.
More Related Videos
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
The JAK-STAT Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Anaphase Promoting Complex
cAMP-dependent Protein Kinase Pathways
Inhibition of Cdk Activity

